# InnovaHealth Partners

InnovaHealth Partners is a Private Equity based in New York, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** New York, NY, United States
- **Founded:** 2016
- **Assets under management:** Undisclosed
- **Website:** innovahealthpartners.com
- **LinkedIn:** https://www.linkedin.com/company/innovahealthpartnerslp

## Regulatory record

- **CRD number:** 297788
- **SEC file number:** 801-126204
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/297788

## About

InnovaHealth Partners is an SEC-registered investment adviser in New York, NY, registered since 2022. The firm manages approximately $301 million in regulatory assets. It has 5 employees and 5 investment advisers.

## Sectors

- Healthcare Services
- Digital Health
- Medical Devices

## Questions

### What is InnovaHealth Partners' investment strategy?

The firm takes a pure-play healthcare approach, spanning growth equity, expansion capital, and buyouts. It concentrates on medical devices, healthcare services, and digital health platforms, writing checks into companies with clinical validation that need capital and operational support to scale. InnovaHealth also conducts early-stage co-investments alongside specialist healthcare venture funds.

### Which sectors does InnovaHealth Partners avoid?

InnovaHealth is exclusively healthcare-focused and does not invest outside the sector. Within healthcare, the firm has not publicly indicated interest in pure biotechnology or early-stage drug discovery, concentrating instead on medical devices, healthcare services, and digital health where regulatory pathways are more established.

### How does InnovaHealth source its deals?

The firm's sourcing relies on a network of healthcare executives, clinicians, and former FDA advisors. This operator-led model gives InnovaHealth access to companies that require specialized diligence — particularly around FDA clearance, reimbursement coding, and clinical adoption — that generalist investors rarely build in-house.

### Where does InnovaHealth invest geographically?

The firm's primary geographic focus is North America, with selected exposure in Western Europe. This aligns with the concentration of FDA-regulated medical device companies and tech-enabled healthcare services platforms that fit the firm's stage and sector criteria.

## Related profiles

- [InnovaFonds](https://altss.com/profile/innovafonds)
- [Innova Italy Partners](https://altss.com/profile/innova-italy-partners)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/innovahealth-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology